Form 4 for IRON Disc Medicine, Inc.
Accepted 2023-09-13 00:00:00 ET · period of report 2023-09-11 · accession 0000950170-23-047933 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-13 | 2023-09-11 | IRON | Bryce Joanne | CFO | M - OptEx | $9.86 | +2,500 | 3,760 | +198% | +$24.6K |
| D | 2023-09-13 | 2023-09-11 | IRON | Bryce Joanne | CFO | M - OptEx | $0.00 | -2,500 | 76.7K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | M | A | 2,500 | $9.86 | 3,760 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-09-11 | M | D | 2,500 | $0.00 | 76,745 | D | $9.86 · — to 2031-09-13 | 2,500 Common Stock | (F1) The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. |